Replies to post #23194 on Cytodyn Inc (CYDY)

[Northstar42]

Yes, 35 subjects have entered the extension study. The primary efficacy endpoint for this study was pegged to 0.05log or greater reduction in
HIV-1 RNA viral load from baseline at the end of the 1 week double blind treatment period. I did not find any reference to another viral reduction value.